Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLAP: Cytarabine in Androgen Independent Prostate Cancer
NCT00480090Phase 2Completed
- Sponsor
- University Health Network
- Start
- Apr 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cytarabine in prostate cancer (PCa), sponsored by University Health Network. Primary endpoint: Prostate Specific Antigen Response. Started Apr 2007; status: completed.
02
Drugs
cytarabine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00480090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00480090.